Cargando…
Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model
PURPOSE: Anti-vascular endothelial growth factor (anti-VEGF) therapies, which attenuate the capacity of VEGF to bind to VEGF receptors, are standard-of-care options for various retinal disorders that are characterized by pathologic retinal angiogenesis and vascular permeability. Multiple receptors a...
Autores principales: | Lange, Claudia, Tetzner, Reimo, Strunz, Tobias, Rittenhouse, Kay D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198290/ https://www.ncbi.nlm.nih.gov/pubmed/37191621 http://dx.doi.org/10.1167/tvst.12.5.17 |
Ejemplares similares
-
Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model
por: Lange, Claudia, et al.
Publicado: (2023) -
Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model
por: Schubert, William, et al.
Publicado: (2022) -
Choroidal Vein Alterations in Pachychoroid Disease With Choroidal Vascular Hyperpermeability: Evaluated by Wide-Field Indocyanine Green Angiography
por: He, Guiqin, et al.
Publicado: (2023) -
Photoreceptor Cells Influence Retinal Vascular Degeneration in Mouse Models of Retinal Degeneration and Diabetes
por: Liu, Haitao, et al.
Publicado: (2016) -
Retinal Vascular Plexuses Are Unequally Affected in Canine Inherited Retinal Degenerations
por: Ripolles-Garcia, Ana, et al.
Publicado: (2022)